Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite ...

Research on hormone therapy reveals critical insights into cardiovascular disease risks, guiding clinicians in selecting ...

"VILPA may be a promising physical activity target for cardiovascular disease prevention, particularly in women unable or not ...

An electronic nudge explaining the cardiovascular benefit of vaccination was particularly effective among survivors of myocardial infarction, reported researchers.

In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term ...

In the CLEAR SYNERGY trial, routine spironolactone after myocardial infarction did not reduce cardiovascular AEs in patients ...

In light of wearable neurotechnologies being developed by Meta, Apple, Snap, and Neuralink, experts called for laws for ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

Philippine Health Insurance Corporation (PhilHealth) announced on Monday new benefit packages covering various illnesses as ...